APA (7th ed.) Citation

Spencer, A., Moreau, P., Mateos, M., Goldschmidt, H., Suzuki, K., Levin, M., . . . Dimopoulos, M. A. (2024). Daratumumab for patients with myeloma with early or late relapse after initial therapy: Subgroup analysis of CASTOR and POLLUX. Blood advances, 8(2), . https://doi.org/10.1182/bloodadvances.2023010579

Chicago Style (17th ed.) Citation

Spencer, Andrew, et al. "Daratumumab for Patients with Myeloma with Early or Late Relapse After Initial Therapy: Subgroup Analysis of CASTOR and POLLUX." Blood Advances 8, no. 2 (2024). https://doi.org/10.1182/bloodadvances.2023010579.

MLA (9th ed.) Citation

Spencer, Andrew, et al. "Daratumumab for Patients with Myeloma with Early or Late Relapse After Initial Therapy: Subgroup Analysis of CASTOR and POLLUX." Blood Advances, vol. 8, no. 2, 2024, https://doi.org/10.1182/bloodadvances.2023010579.